Quality of life and sociodemographic and clinical profile of breast and prostate cancer patients
DOI:
https://doi.org/10.15253/2175-6783.20232489231Keywords:
Breast Neoplasms; Prostatic Neoplasms; Quality of Life; Oncology Nursing; Nursing Care.Abstract
Objective: to assess the association between health-related quality of life and sociodemographic and clinical characteristics of breast and prostate cancer patients. Methods: a cross-sectional study of 305 patients was performed. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, the Quality of Life Questionnaire Breast Cancer, and a structured instrument were used. Descriptive and inferential statistical analyses were performed. Results: the study revealed a prevalence of patients aged 50-69 years, married, with 13 or more years of education, retired, with an income of up to two minimum wages, and receiving radiotherapy for breast cancer. Significant associations were observed between the Global Health Scale and gender and marital status, the Functional Scale and age group and family income, the Symptom Scale and gender, age group, cancer type, and current treatment, and between the Global Health Scale and cancer type, current treatment, treatment duration, lack of companion, and number of comorbidities. Conclusions: health-related quality of life in breast and prostate cancer patients is negatively influenced by sociodemographic and clinical characteristics. Contributions to practice: the data provide insights for designing individualized care plans.
References
Santos MO, Lima FCSD, Martins LFL, Oliveira JFP, Almeida LMD, Cancela MC. Estimated cancer incidence in Brazil, 2023-2025. Rev Bras Cance- rol. 2023;69(1):e-213700. doi: https://dx.doi.org/10.32635/2176-9745.RBC.2023v69n1.3700
Carlos EA, Borgato JA, Garbio DC. Evaluation of the quality of life of cancer patients undergoing chemotherapy. Rev Rene. 2022;23:e71133. doi: https://doi.org/10.15253/2175-6783.20222371133
Salvetti MG, Machado CSP, Donato SCT, Silva AMD. Prevalence of symptoms and quality of life of cancer patients. Rev Bras Enferm. 2020;73(2):e20180287. doi: http://doi.org/10.1590/0034-7167-2018-0287
Silveira FM, Wysocki AD, Mendez RD, Pena SB, Santos EM, Malaguti-Toffano S, et al. Impact of chemotherapy treatment on the quality of life of patients with cancer. Acta Paul Enferm. 2021;34:eAPE00583. doi: https://dx.doi.org/10.37689/actaape/2021AO00583
Lima EOL, Silva MMD. Quality of life of women with locally advanced or metastatic breast cancer. Rev Gaúcha Enferm. 2020;41:e20190292. doi: https://doi.org/10.1590/1983-1447.2020.20190292
Medeiros MBD, Silva RMCRA, Pereira ER, Melo SHDS, Joaquim FL, Santos BMD, et al. Perception of women with breast cancer undergoing chemotherapy: a comprehensive analysis. Rev Bras Enferm. 2019;72(Suppl 3):103-10. doi: https://doi.org/10.1590/0034-7167-2018-0165
Rocha DM, Pedrosa AO, Oliveira ACD, Benício CD, Santos AMD, Nogueira LT. Predictors and quality of life in patients with radiodermatitis: a longitudinal study. Acta Paul Enferm. 2021;34:eAPE01063. doi: http://dx.doi.org/10.37689/actaape/2021AO01063
Salgado NDM, Silva FRF, Souza JCFD, Chagas JMA, Botelho LL, Gonçalves LSF, et al. Psychological impacts of mastectomy due to breast cancer in women’s lives. Rev Eletr Acervo Cientif. 2021;31:1-6. doi: https://doi.org/10.25248/REAC.e8386.2021
Bardaweel SK, Akour AA, Al-Muhaissen S, AlSalamat HA, Ammar K. Oral contraceptive and breast cancer: do benefits outweigh the risks? A case - control study from Jordan. BMC Womens Health. 2019;319(1):72. doi: https://dx.doi.org/10.1186/s12905-019-0770-x
Araújo JS, Zago MMF. Masculinities of prostate cancer survivors: a qualitative metasynthesis. Rev Bras Enferm. 2019;72(1):231-40. doi: http://dx.doi.org/10.1590/0034-7167-2017-0730
Abedalrahman SK, Ali BM, Al-Khalidy NAI, Al-Hashimi AS. Risk factors of breast cancer among Iraqi women. J Contemp Med Sci. 2019;3(5):149-53. doi: https://doi.org/10.22317/jcms.v5i3.609
Michels FAS, Latorre, MRDS, Maciel MS. Validity, reliability and understanding of the EORTC-C30 and EORTC-BR23, quality of life questionnaires specific for breast cancer. Rev Bras Epidemiol. 2013;16(2):352-63. doi: https://doi.org/10.1590/S1415-790X2013000200011
Gregorowitsch ML, Ghedri A, Young-Afat DA, Bijlsma R, Baas IO, Van Schaik‑van de Mheen C, et al. The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients. Breast Cancer Res Treat. 2019;175(2):429-41. doi: https://dx.doi.org/10.1007/s10549-019-05149-4
Oliveira DAL, Silva LBF, Alves SKM, Guerra MCGC, Ramos VP. Social network support for women with breast cancer undergoing chemotherapy. Rev Enferm Digit Cuid Prom Saúde. 2023;8:1-8. doi: https://doi.org/10.5935/2446-5682.20230186
Dano D, Hénon C, Sarr O, Ka K, Ba M, Badiane A, et al. Quality of life during chemotherapy for breast cancer in a west African population in Dakar, Senegal: a prospective study. J Glob Oncol. 2019;5:1-9. doi: https://ascopubs.org/doi/full/10.1200/JGO.19.00106
Nunes MAH, Ceolim MF. Quality of sleep and symptom cluster in cancer patients undergoing chemotherapy treatment. Cogitare Enferm. 2019;24:e58046. doi: http://dx.doi.org/10.5380/ce.v24i0.58046
Silva PR, Cruz LAP, Nascimento TG, Gozzo TO. Sleep quality and fatigue in women with breast cancer during chemotherapy. Rev Enferm UFSM. 2019;9:e20. doi: https://dx.doi.org/10.5902/2179769232732
Bedoya AM, Arcila AL, Cardona-Arias JA. Factores de riesgo para el cáncer de mama. Rev Cubana Obstet Ginecol [Internet]. 2019 [cited May 23, 2023];45(2):e370. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-600X2019000200002&lng=es
Pereira LDA, Musso MAA, Calmon MV, Souza CBD, Zandonade E, Costa Neto SB, et al. Quality of life of women with breast cancer in the preoperative, postoperative and chemotherapy treatments. Braz J Hea Rev. 2021;4(2):6647-62. doi: https://doi.org/10.34119/bjhrv4n2-216
Tran TH, Trinh NL, Hoang Y, Nguyen TL, Vu TT. Health-related quality of life among vietnamese breast cancer women. Cancer Control. 2019;26(1):1073274819862787. doi: http://doi.org/10.1177/1073274819862787
Vassilievitch AC, Amorim BF, Kameo SY, Silva GO, Sawada NO. Sociodemographic and quality of life analysis related to the health of women with breast cancer after chemotherapy treatment. RG&PP. 2020;10(1):139-55. doi: https://dx.doi.org/10.11606/rgpp.v10i1.175028
Sant’Anna SS, Rosa RS, Gomes LOS, Souza FS, Biondo CS. Repercussions in the family context of patients with prostate cancer. Rev Salud Pública. 2022;24(5):1-8. doi: https://doi.org/10.15446/rsap.v24n5.65435
Silva WA, Ramos MJO, Carvalho MGMD, Dinizio VGO, Dantas VGV, Kameo SY. Cryotherapy for reduction of chemotherapy-induced alopecia: use in women with breast cancer. Rev Soc Dev. 2022;11(17):e117111738926. doi: http://dx.doi.org/10.33448/rsd-v11i17.38926
Imran M, Al-Wassia R, Alkhayyat SS, Baig M, Al-Saati BA. Assessment of quality of life (QoL) in breast cancer patients by using EORTC QLQ-C30 and BR-23 questionnaires: a tertiary care center survey in the western region of Saudi Arabia. PLoS One. 2019;14(7):e0219093. doi: https://dx.doi.org/10.1371/journal.pone.0219093
Ligt KM, Heins M, Verloop J, Ezendam NPM, Smorenburg CH, Korevaar JC. The impact of health symptoms on health‑related quality of life in early‑stage breast cancer survivors. Breast Cancer Res Treat. 2019;178(3):703-11. doi: https://doi.org/10.1007/s10549-019-05433-3
Lee Y, Baek JM, Ye-Won J, Eun-Ok IM. Illness perception and sense of well-being in breast cancer patients. Patient Prefer Adherence. 2019;13:1557-67. doi: https://doi.org/10.2147/PPA.S225561
Castillo-Otiniano CC, Yan-Quiroz EF. Hipertensión arterial y diabetes mellitus como factores de riesgo para el cáncer de mama. Rev Cuerpo Méd. 2019;12(1):35-9. doi: https://doi.org/10.35434/rcmhnaaa.2019.121.483
